世界の同種細胞療法市場は、2022年に約2億5,560万米ドルと評価され、予測期間の2023年から2030年には27.40%以上の堅調な成長率で成長すると予測されています。同種細胞療法は、細胞療法の一種で、ドナーからの細胞を使用して患者を治療します。この種の治療では、健康なドナーから細胞を採取し、実験室で処理・増殖させてから患者に注入します。同種細胞療法に使用される細胞は、幹細胞、免疫細胞、または治療可能な他の特殊な細胞を含む様々なタイプの細胞であり得ます。細胞は通常、患者の体内で損傷したり機能不全に陥った細胞を置き換えたり、特定の病気と闘うために免疫系を調整したりする能力に基づいて選択されます。同種細胞療法市場は、がんの有病率の上昇や同種細胞療法のFDA承認の増加などの要因によって促進されています。
同種細胞療法は、がん、遺伝性疾患、自己免疫疾患など、さまざまな疾患の治療に使用されています。この治療法は臨床試験で有望な結果を示しており、研究者はさまざまな疾患の治療に対するその可能性を調査し続けています。国際がん研究機関（IARC）の予測によると、世界のがんの新規発生件数は、2021年の190万件から2040年には2,750万件に達すると予測されており、世界のがんの流行が市場の成長を促しています。慢性疾患に対する最先端医療への需要の高まりに伴って、細胞治療薬の臨床試験が増加しています。提供された情報によると、2021年4月時点で実施中の細胞治療の臨床試験は1,358件で、2019年から2020年にかけて24％、2020年から2021年にかけて43％増加しました。83%拡大したCAR-T細胞の臨床試験が、この拡大のほとんどを占めています。このように、世界中で臨床試験数が増加していることが、市場成長のケータリングとなっています。さらに、幹細胞治療に対する政府の助成金の増加や、細胞を用いた臨床試験の活発化も、市場の有利な成長を生み出しています。BLAは2023年第4四半期末に提出される予定です。このTherapy Typemの発売が成功すれば、患者に代替の選択肢を提供することができます。しかし、同種細胞療法のコストの高さが、2023年から2030年の予測期間を通じて市場の成長を阻害します。
同種細胞療法の世界市場調査において考慮した主要地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他世界のその他の地域です。北アメリカは、ブランド品の人気とこの地域の疾病率の上昇の結果、2022年に市場を独占しました。2020年には約3,730万人のアメリカ人が糖尿病を患い、そのうち2,870万件はすでに診断を受けているケース、850万件は診断を受けていないケースであると言われています。アジア太平洋は、老年人口や対象人口の発展、バイオシミラー開発のための共同研究件数の増加、主要企業の地理的拡大、政府機関や非営利団体の市場参入への積極的参加などの要因により、予測期間中に最も高いCAGRで成長すると予測されています。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Allogeneic Cell Therapy Market, by Region, 2020-2030 (USD Million)
1.2.2. Allogeneic Cell Therapy Market, by Therapy Type, 2020-2030 (USD Million)
1.2.3. Allogeneic Cell Therapy Market, by Therapeutic Area, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Allogeneic Cell Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Allogeneic Cell Therapy Market Dynamics
3.1. Allogeneic Cell Therapy Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of cancer
3.1.1.2. Increasing FDA approvals of allogeneic cell therapies
3.1.2. Market Challenges
3.1.2.1. High research costs and challenges with immune rejection
3.1.3. Market Opportunities
3.1.3.1. Increasing government funding for stem cell therapies
3.1.3.2. Rising cell based clinical trial activities
Chapter 4. Global Allogeneic Cell Therapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Allogeneic Cell Therapy Market, by Therapy type
5.1. Market Snapshot
5.2. Global Allogeneic Cell Therapy Market by Therapy type, Performance - Potential Analysis
5.3. Global Allogeneic Cell Therapy Market Estimates & Forecasts by Therapy type 2020-2030 (USD Million)
5.4. Allogeneic Cell Therapy Market, Sub Segment Analysis
5.4.1. Stem Cell Therapies
5.4.2. Non-stem Cell Therapies
Chapter 6. Global Allogeneic Cell Therapy Market, by Therapeutic Area
6.1. Market Snapshot
6.2. Global Allogeneic Cell Therapy Market by Therapeutic Area, Performance - Potential Analysis
6.3. Global Allogeneic Cell Therapy Market Estimates & Forecasts by Therapeutic Area 2020-2030 (USD Million)
6.4. Allogeneic Cell Therapy Market, Sub Segment Analysis
6.4.1. Haematological Disorders
6.4.2. Dermatological Disorders
6.4.3. Others
Chapter 7. Global Allogeneic Cell Therapy Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Allogeneic Cell Therapy Market, Regional Market Snapshot
7.4. North America Allogeneic Cell Therapy Market
7.4.1. U.S. Allogeneic Cell Therapy Market
7.4.1.1. Therapy type breakdown estimates & forecasts, 2020-2030
7.4.1.2. Therapeutic Area breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Allogeneic Cell Therapy Market
7.5. Europe Allogeneic Cell Therapy Market Snapshot
7.5.1. U.K. Allogeneic Cell Therapy Market
7.5.2. Germany Allogeneic Cell Therapy Market
7.5.3. France Allogeneic Cell Therapy Market
7.5.4. Spain Allogeneic Cell Therapy Market
7.5.5. Italy Allogeneic Cell Therapy Market
7.5.6. Rest of Europe Allogeneic Cell Therapy Market
7.6. Asia-Pacific Allogeneic Cell Therapy Market Snapshot
7.6.1. China Allogeneic Cell Therapy Market
7.6.2. India Allogeneic Cell Therapy Market
7.6.3. Japan Allogeneic Cell Therapy Market
7.6.4. Australia Allogeneic Cell Therapy Market
7.6.5. South Korea Allogeneic Cell Therapy Market
7.6.6. Rest of Asia Pacific Allogeneic Cell Therapy Market
7.7. Latin America Allogeneic Cell Therapy Market Snapshot
7.7.1. Brazil Allogeneic Cell Therapy Market
7.7.2. Mexico Allogeneic Cell Therapy Market
7.8. Rest of The World Allogeneic Cell Therapy Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. JCR Pharmaceuticals Co., Ltd.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Therapy TypeSummary
8.3.1.5. Recent Developments
8.3.2. Sumitomo Pharma Co., Ltd.
8.3.3. Atara Biotherapeutics Inc.
8.3.4. Mallinckrodt Pharmaceuticals
8.3.5. Tego Science Inc.
8.3.6. Takeda Pharmaceutical Company Limited.
8.3.7. STEMPEUTICS RESEARCH PVT LTD.
8.3.8. Biosolution Co., Ltd.
8.3.9. MEDIPOST Co., Ltd.
8.3.10. LifeSouth Community Blood Centers, Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Allogeneic Cell Therapy Market, report scope
TABLE 2. Global Allogeneic Cell Therapy Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Allogeneic Cell Therapy Market estimates & forecasts by Therapy type 2020-2030 (USD Million)
TABLE 4. Global Allogeneic Cell Therapy Market estimates & forecasts by Therapeutic Area 2020-2030 (USD Million)
TABLE 5. Global Allogeneic Cell Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 6. Global Allogeneic Cell Therapy Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Allogeneic Cell Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Allogeneic Cell Therapy Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Allogeneic Cell Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Allogeneic Cell Therapy Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Allogeneic Cell Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Allogeneic Cell Therapy Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Allogeneic Cell Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Allogeneic Cell Therapy Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. U.S. Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 17. U.S. Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. Canada Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 19. Canada Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. Canada Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. UK Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 22. UK Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. UK Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. Germany Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 25. Germany Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. Germany Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. France Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 28. France Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. France Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. Italy Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 31. Italy Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. Italy Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Spain Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 34. Spain Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Spain Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. RoE Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 37. RoE Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. RoE Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. China Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 40. China Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. China Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. India Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 43. India Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. India Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. Japan Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 46. Japan Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. Japan Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. South Korea Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 49. South Korea Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. South Korea Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. Australia Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 52. Australia Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. Australia Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. RoAPAC Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 55. RoAPAC Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. RoAPAC Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. Brazil Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 58. Brazil Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. Brazil Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Mexico Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 61. Mexico Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Mexico Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. RoLA Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 64. RoLA Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. RoLA Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. Saudi Arabia Allogeneic Cell Therapy Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 67. South Africa Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. RoMEA Allogeneic Cell Therapy Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Allogeneic Cell Therapy Market
TABLE 70. List of primary sources, used in the study of global Allogeneic Cell Therapy Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Allogeneic Cell Therapy Market, research methodology
FIG 2. Global Allogeneic Cell Therapy Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Allogeneic Cell Therapy Market, key trends 2022
FIG 5. Global Allogeneic Cell Therapy Market, growth prospects 2023-2030
FIG 6. Global Allogeneic Cell Therapy Market, porters 5 force model
FIG 7. Global Allogeneic Cell Therapy Market, pest analysis
FIG 8. Global Allogeneic Cell Therapy Market, value chain analysis
FIG 9. Global Allogeneic Cell Therapy Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Allogeneic Cell Therapy Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Allogeneic Cell Therapy Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Allogeneic Cell Therapy Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Allogeneic Cell Therapy Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Allogeneic Cell Therapy Market, regional snapshot 2020 & 2030
FIG 15. North America Allogeneic Cell Therapy Market 2020 & 2030 (USD Million)
FIG 16. Europe Allogeneic Cell Therapy Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Allogeneic Cell Therapy Market 2020 & 2030 (USD Million)
FIG 18. Latin America Allogeneic Cell Therapy Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Allogeneic Cell Therapy Market 2020 & 2030 (USD Million)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
